This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Rhizen Pharmaceuticals Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Sridhar Veeraraghavan: Innovator in Kinase Inhibition
Introduction
Sridhar Veeraraghavan is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel inhibitors for kinase-mediated diseases.
Latest Patents
One of his key patents is titled "Purine derivatives as SIK-3 inhibitors." This invention relates to innovative inhibitors of salt-inducible kinase-3 (SIK3). The patent outlines methods for preparing these inhibitors, pharmaceutical compositions that contain them, and their application in treating or preventing kinase-mediated diseases or disorders.
Career Highlights
Sridhar currently works at Rhizen Pharmaceuticals AG, where he continues to advance research in the pharmaceutical sector. His work focuses on developing therapeutic solutions that address critical health challenges.
Collaborations
He collaborates with esteemed colleagues such as Prashant K Bhavar and Srikant Viswanadha, contributing to a dynamic research environment that fosters innovation.
Conclusion
Sridhar Veeraraghavan's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in kinase inhibition, highlight the importance of research in developing effective treatments for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile